Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker JOF
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 1,300 | $10.80 | $14.0K Buy | Form 4 ↗ |
| Nov 5, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 28,208 | $10.61 | $299.3K Buy | Form 4 ↗ |
| Nov 3, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Sale | 16,200 | $11.07 | $179.3K Sale | Form 4 ↗ |
| Nov 2, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 2,720 | $11.00 | $29.9K Buy | Form 4 ↗ |
| Oct 30, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 58,686 | $10.98 | $644.4K Buy | Form 4 ↗ |
| Oct 29, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 5,083 | $11.31 | $57.5K Buy | Form 4 ↗ |
| Oct 28, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 15,967 | $11.38 | $181.7K Buy | Form 4 ↗ |
| Oct 19, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 30,000 | $11.94 | $358.2K Buy | Form 4 ↗ |
| Oct 16, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 16,222 | $11.94 | $193.7K Buy | Form 4 ↗ |
| Oct 14, 2026 | Saba Capital Management, L.P. 10% owner | JOF Japan Smaller Capitalization Fund Inc | Buy | 13,133 | $12.33 | $161.9K Buy | Form 4 ↗ |
| Dec 22, 2025 | Tina Jones Director | JOF Japan Smaller Capitalization Fund Inc | Buy | 950 | $10.80 | $10.3K Buy | Form 4 ↗ |
| Sep 17, 2025 | David B. Chemidlin Director | JOF Japan Smaller Capitalization Fund Inc | Buy | 2,000 | $10.90 | $21.8K Buy | Form 4 ↗ |
| Jan 13, 2025 | Arthur Blake Laby Director | JOF Japan Smaller Capitalization Fund Inc | Buy | 3,306 | $7.56 | $25.0K Buy | Form 4 ↗ |
| Dec 11, 2024 | Paige Ouimet Director | JOF Japan Smaller Capitalization Fund Inc | Buy | 3,111 | $8.02 | $25.0K Buy | Form 4 ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances